Welcome to our dedicated page for Isoplexis news (Ticker: ISO), a resource for investors and traders seeking the latest updates and insights on Isoplexis stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Isoplexis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Isoplexis's position in the market.
IsoPlexis Corporation has successfully closed its initial public offering of 8,333,000 shares of common stock at $15.00 per share, raising gross proceeds of $125 million. The shares began trading on Nasdaq under the ticker symbol "ISO" on October 8, 2021. Notably, all shares in this offering were offered by IsoPlexis itself. The offering was led by Morgan Stanley, Cowen, Evercore ISI, and SVB Leerink, with a registration statement declared effective by the SEC on October 7, 2021.
IsoPlexis Corporation has priced its initial public offering of 8,333,000 shares at $15.00 each, aiming for gross proceeds of $125 million, excluding underwriters' options. Trading on Nasdaq under the symbol 'ISO' is set for October 8, 2021, with the offering expected to close on October 12, 2021. The offering's lead managers are Morgan Stanley, Cowen, Evercore ISI, and SVB Leerink. Forward-looking statements are included, with no guarantee that the offering will be completed as described.
FAQ
What is the market cap of Isoplexis (ISO)?
